Johnson Investment Counsel »

Ocuphire Pharma shares owned by Johnson Investment Counsel

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Johnson Investment Counsel from 13F filings

Historical chart of Johnson Investment Counsel investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Johnson Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Johnson Investment Counsel

Quarter filed Position value Share count Share price at filing
2025-12-31 $40k 20k 2.01

More positions owned by Johnson Investment Counsel

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Etf (IWB)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Ishares Tr Rus Mid Cap Etf (IWR)
Cincinnati Financial Corporation (CINF)
Amazon (AMZN)
Ab Active Etfs Intl Low Volatlt (ILOW)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Williams Companies (WMB)
Nvent Electric SHS (NVT)
Mastercard Incorporated Cl A (MA)
Nasdaq Omx (NDAQ)

View all positions for Johnson Investment Counsel

Top funds holding Ocuphire Pharma

Nantahala Capital Management
Perceptive Advisors
BIOS Capital Management
Vanguard Group
Mink Brook Asset Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Geode Capital Management
Voss Capital
Susquehanna International
Wells Fargo & Company
State Street Corporation
Marshall Wace
BlackRock

View all funds holding Ocuphire Pharma